Medicamen Biotech Limited (NSE:MEDICAMEQ)

Medicamen Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	37.59	147.86	207.79	38.25	38.91
Cash & Short-Term Investments	37.59	147.86	207.79	38.25	38.91
Cash Growth	-74.57%	-28.84%	443.26%	-1.69%	25.80%
Accounts Receivable	689	552.59	652.58	632.24	525.47
Other Receivables	-	223.43	219.83	196.18	225.22
Receivables	719.88	776.03	872.41	828.42	750.69
Inventory	621.37	593.75	450.57	270.1	52.04
Prepaid Expenses	-	1.57	0.65	7.35	4.26
Other Current Assets	266.64	76.73	102.21	86.26	114.43
Total Current Assets	1,645	1,596	1,634	1,230	960.33
Property, Plant & Equipment	861.16	909.52	917.59	921.18	894.35
Other Intangible Assets	7.42	8.98	8.98	3.6	2.04
Long-Term Deferred Tax Assets	28.07	25.15	18.8	4.96	-2.83
Long-Term Deferred Charges	414.22	393.73	195.12	88.17	75.6
Other Long-Term Assets	12.45	12.19	11.07	8.65	7.75
Total Assets	2,969	2,946	2,785	2,257	1,937
Accounts Payable	425.96	334.57	416.52	393.12	274.34
Accrued Expenses	8.14	68.45	53.3	37.81	51.37
Short-Term Debt	295.19	295.62	233.13	192.75	109.29
Current Portion of Long-Term Debt	-	2.94	15.26	14.47	14.86
Current Income Taxes Payable	33.08	40.63	37	42.64	46
Current Unearned Revenue	-	3.18	21.31	14.41	4.75
Other Current Liabilities	19.29	100.17	49.22	31.71	32.13
Total Current Liabilities	781.65	845.55	825.74	726.91	532.74
Long-Term Debt	37.34	12.56	8.7	50.74	64.05
Long-Term Deferred Tax Liabilities	-0.03	-	-	-	-
Other Long-Term Liabilities	22.04	2.93	3.45	3.62	2.28
Total Liabilities	841.01	875.67	851.03	792.24	608.34
Common Stock	127.15	127.15	126.51	122.17	122.17
Additional Paid-In Capital	-	1,023	978.73	677.05	677.04
Retained Earnings	-	907.67	825.38	687.82	551.07
Comprehensive Income & Other	2,001	-7.01	-12.14	-22.34	-21.39
Total Common Equity	2,128	2,051	1,918	1,465	1,329
Minority Interest	-	18.92	15.66	-	-
Shareholders' Equity	2,128	2,070	1,934	1,465	1,329
Total Liabilities & Equity	2,969	2,946	2,785	2,257	1,937
Total Debt	332.53	311.12	257.09	257.96	188.19
Net Cash (Debt)	-294.94	-163.26	-49.3	-219.71	-149.29
Net Cash Per Share	-23.20	-12.90	-3.90	-17.98	-12.22
Filing Date Shares Outstanding	12.71	12.71	12.65	12.22	12.22
Total Common Shares Outstanding	12.71	12.71	12.65	12.22	12.22
Working Capital	863.84	750.38	807.89	503.47	427.59
Book Value Per Share	167.35	161.30	151.65	119.89	108.78
Tangible Book Value	2,120	2,042	1,910	1,461	1,327
Tangible Book Value Per Share	166.77	160.60	150.94	119.60	108.61
Land	-	9.42	9.42	9.42	9.42
Buildings	-	373.19	371.88	370.28	341.95
Machinery	-	966.94	907.24	853.66	798.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.